Cocrystal(COCP) - 2023 Q4 - Annual Results

BOTHELL, Wash. (March 28, 2024) – Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) reports financial results for the 12 months ended December 31, 2023, and provides updates on its antiviral product pipeline, upcoming milestones and business activities. Exhibit 99.1 Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs "We are highly encouraged by the FDA's feedback to our Pre-Investigational New Drug (Pre-IND) package, which provides ...